Better Quality of Life with Less Pain After Strontium-89 Therapy for Prostate Cancer
Author Information
Author(s): Turner S L, Gruenewald S, Spry N, Gebski V
Primary Institution: Department of Radiation Oncology, Westmead Hospital, NSW, Australia
Hypothesis
Does pain reduction after strontium-89 therapy improve quality of life in patients with metastatic prostate cancer?
Conclusion
Patients who experienced pain relief after strontium-89 therapy showed significant improvements in quality of life.
Supporting Evidence
- 63% of patients achieved pain responses after treatment.
- Quality of life significantly improved within 6 weeks for those with pain relief.
- PSA response did not correlate with clinical improvement.
Takeaway
If you feel less pain after treatment for prostate cancer, you might feel better overall too.
Methodology
Patients were assessed for pain and quality of life before and after receiving strontium-89 therapy.
Limitations
Overall quality of life improvement was limited, and not all patients experienced pain relief.
Participant Demographics
Patients with hormone refractory metastatic prostate cancer.
Statistical Information
P-Value
0.004
Statistical Significance
p=0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website